Drug intelligence / Profile preview

Idavir

Development stage: Unknown
Lead developer: Shandong Provincial Qianfoshan Hospital
Administration: Intraperitoneal

Overview

Idavir is a peritoneal dialysis solution indicated for the treatment of End-stage renal disease stage 5. Peritoneal dialysis solutions function by establishing an osmotic gradient across the peritoneal membrane, facilitating the removal of metabolic waste products and excess fluid from the patient's blood into the dialysate. This process helps to manage the symptoms and complications associated with severe kidney failure.

Other names: 依达维腹膜透析液

Beyond the preview

Go deeper on Idavir.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Idavir.

Explore the full profile